BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18922875)

  • 1. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections.
    Krenn BM; Gaudernak E; Holzer B; Lanke K; Van Kuppeveld FJ; Seipelt J
    J Virol; 2009 Jan; 83(1):58-64. PubMed ID: 18922875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells.
    Lanke K; Krenn BM; Melchers WJG; Seipelt J; van Kuppeveld FJM
    J Gen Virol; 2007 Apr; 88(Pt 4):1206-1217. PubMed ID: 17374764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc ionophores pyrithione inhibits herpes simplex virus replication through interfering with proteasome function and NF-κB activation.
    Qiu M; Chen Y; Chu Y; Song S; Yang N; Gao J; Wu Z
    Antiviral Res; 2013 Oct; 100(1):44-53. PubMed ID: 23867132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.
    Krenn BM; Holzer B; Gaudernak E; Triendl A; van Kuppeveld FJ; Seipelt J
    J Virol; 2005 Nov; 79(22):13892-9. PubMed ID: 16254325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The processing of eIF4GI by human rhinovirus type 2 2A(pro): relationship to self-cleavage and role of zinc.
    Glaser W; Triendl A; Skern T
    J Virol; 2003 Apr; 77(8):5021-5. PubMed ID: 12663811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrithione, a zinc ionophore, inhibits NF-kappaB activation.
    Kim CH; Kim JH; Moon SJ; Chung KC; Hsu CY; Seo JT; Ahn YS
    Biochem Biophys Res Commun; 1999 Jun; 259(3):505-9. PubMed ID: 10364448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders.
    Fois B; Bianco G; Sonar VP; Distinto S; Maccioni E; Meleddu R; Melis C; Marras L; Pompei R; Floris C; Caboni P; Cottiglia F
    J Nat Prod; 2017 Oct; 80(10):2799-2806. PubMed ID: 29039946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro antiviral activity of a triazinoindole (SK&F 40491).
    Haff RF; Flagg WB; Gallo JJ; Hoover JR; Miller JA; Pinto CA; Pagano JF
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):475-8. PubMed ID: 4344266
    [No Abstract]   [Full Text] [Related]  

  • 9. Blocking human enterovirus 71 replication by targeting viral 2A protease.
    Falah N; Montserret R; Lelogeais V; Schuffenecker I; Lina B; Cortay JC; Violot S
    J Antimicrob Chemother; 2012 Dec; 67(12):2865-9. PubMed ID: 22865380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of enterovirus 2A protease-associated viral IRES activities by the cell's ERK signaling cascade: Implicating ERK as an efficiently antiviral target.
    Duan H; Zhu M; Xiong Q; Wang Y; Xu C; Sun J; Wang C; Zhang H; Xu P; Peng Y
    Antiviral Res; 2017 Jul; 143():13-21. PubMed ID: 28351508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
    Tonew M; Tonew E; Oehring H; Schmidt J
    Virologie; 1985; 36(2):111-7. PubMed ID: 2994289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc ions inhibit replication of rhinoviruses.
    Korant BD; Kauer JC; Butterworth BE
    Nature; 1974 Apr; 248(449):588-90. PubMed ID: 4363085
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase.
    Deszcz L; Seipelt J; Vassilieva E; Roetzer A; Kuechler E
    FEBS Lett; 2004 Feb; 560(1-3):51-5. PubMed ID: 14987997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.
    Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung YS; Neyts J; Olkkonen VM; van Kuppeveld FJM; Strating JRPM
    Antiviral Res; 2017 Apr; 140():37-44. PubMed ID: 28088354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imid azo[1,2-a]pyridines as a novel class of inhibitors of human rhinovirus: stereospecific synthesis and antiviral activity.
    Hamdouchi C; de Blas J; del Prado M; Gruber J; Heinz BA; Vance L
    J Med Chem; 1999 Jan; 42(1):50-9. PubMed ID: 9888832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections.
    Hoang BX; Han B
    Med Hypotheses; 2020 Dec; 145():110333. PubMed ID: 33045596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
    Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
    Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combating enterovirus replication: state-of-the-art on antiviral research.
    Thibaut HJ; De Palma AM; Neyts J
    Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing and quantifying the differential cleavages of the eukaryotic translation initiation factors eIF4GI and eIF4GII in the enterovirus-infected cell.
    Hsu YY; Liu YN; Lu WW; Kung SH
    Biotechnol Bioeng; 2009 Dec; 104(6):1142-52. PubMed ID: 19655339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.